Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size, Status and Forecast 2025

This report studies the global Pulmonary Arterial Hypertension (PAH) Medicine market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Pulmonary Arterial Hypertension (PAH) Medicine market by companies, region, type and end-use industry.

In 2017, the global Pulmonary Arterial Hypertension (PAH) Medicine market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered
Pfizer
Gilead Sciences
Eli Lilly
Actelion Pharmaceuticals
United Therapeutics Corporation
...

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Market segment by Type, the product can be split into
Calcium Channel Blockers
Novel Targeted Drugs
Other

Market segment by Application, split into
Secondary Pulmonary Hypertension (SPH)
Primary Pulmonary Hypertension (PPH)

The study objectives of this report are:
To study and forecast the market size of Pulmonary Arterial Hypertension (PAH) Medicine in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pulmonary Arterial Hypertension (PAH) Medicine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers
Pulmonary Arterial Hypertension (PAH) Medicine Distributors/Traders/Wholesalers
Pulmonary Arterial Hypertension (PAH) Medicine Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Pulmonary Arterial Hypertension (PAH) Medicine market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size, Status and Forecast 2025
1 Industry Overview of Pulmonary Arterial Hypertension (PAH) Medicine
1.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Overview
1.1.1 Pulmonary Arterial Hypertension (PAH) Medicine Product Scope
1.1.2 Market Status and Outlook
1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Pulmonary Arterial Hypertension (PAH) Medicine Market by Type
1.3.1 Calcium Channel Blockers
1.3.2 Novel Targeted Drugs
1.3.3 Other
1.4 Pulmonary Arterial Hypertension (PAH) Medicine Market by End Users/Application
1.4.1 Secondary Pulmonary Hypertension (SPH)
1.4.2 Primary Pulmonary Hypertension (PPH)

2 Global Pulmonary Arterial Hypertension (PAH) Medicine Competition Analysis by Players
2.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)
3.2 Gilead Sciences
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)
3.3 Eli Lilly
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)
3.4 Actelion Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)
3.5 United Therapeutics Corporation
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) (2013-2018)

4 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type and Application (2013-2018)
4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018)
4.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
4.3 Potential Application of Pulmonary Arterial Hypertension (PAH) Medicine in Future
4.4 Top Consumer/End Users of Pulmonary Arterial Hypertension (PAH) Medicine

5 United States Pulmonary Arterial Hypertension (PAH) Medicine Development Status and Outlook
5.1 United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
5.2 United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
5.3 United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

6 Europe Pulmonary Arterial Hypertension (PAH) Medicine Development Status and Outlook
6.1 Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
6.2 Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
6.3 Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

7 China Pulmonary Arterial Hypertension (PAH) Medicine Development Status and Outlook
7.1 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
7.2 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
7.3 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

8 Japan Pulmonary Arterial Hypertension (PAH) Medicine Development Status and Outlook
8.1 Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
8.2 Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
8.3 Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

9 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Development Status and Outlook
9.1 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
9.2 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

10 India Pulmonary Arterial Hypertension (PAH) Medicine Development Status and Outlook
10.1 India Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
10.2 India Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Market Share by Players (2013-2018)
10.3 India Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Value) by Regions (2018-2025)
11.1.1 United States Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
11.1.2 Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
11.1.3 China Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
11.1.4 Japan Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
11.1.6 India Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate (2018-2025)
11.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Value) by Type (2018-2025)
11.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2018-2025)

12 Pulmonary Arterial Hypertension (PAH) Medicine Market Dynamics
12.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Opportunities
12.2 Pulmonary Arterial Hypertension (PAH) Medicine Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Pulmonary Arterial Hypertension (PAH) Medicine Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Pulmonary Arterial Hypertension (PAH) Medicine Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Regions (2013-2018)
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Type in 2017
Figure Calcium Channel Blockers Market Size (Million USD) and Growth Rate (2013-2018)
Figure Novel Targeted Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Other Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application in 2017
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate in Secondary Pulmonary Hypertension (SPH) (2013-2018)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate in Primary Pulmonary Hypertension (PPH) (2013-2018)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate in Applications 3 (2013-2018)
Table Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table Gilead Sciences Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of Gilead Sciences (2013-2018)
Figure Gilead Sciences Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of Eli Lilly (2013-2018)
Figure Eli Lilly Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table Actelion Pharmaceuticals Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of Actelion Pharmaceuticals (2013-2018)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table United Therapeutics Corporation Basic Information List
Table Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue (Million USD) of United Therapeutics Corporation (2013-2018)
Figure United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Medicine Business Revenue Market Share (2013-2018)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Product (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Product (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Product in 2017
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Pulmonary Arterial Hypertension (PAH) Medicine
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table China Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table China Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) and Growth Rate (2013-2018)
Table India Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Players (2013-2018)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2013
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Players in 2017
Table India Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (%) by Application (2013-2018)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application in 2017
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Growth Rate (2018-2025)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Regions (2018-2025)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share (2018-2025)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Regions in 2025
Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Type (2018-2025)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Type in 2018
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Type in 2025
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Application (2018-2025)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD) by Application in 2018

Choose License Type